Cargando…
An injectable copolymer of fatty acids (ARA 3000 BETA) as a promising treatment for osteoarthritis
Osteoarthritis (OA) is the most prevalent rheumatic disease and a fast growing cause of disability. Current pharmacological treatments include antalgics and non-steroid anti-inflammatory drugs to control pain and inflammation as well as slow acting drugs such as intra-articular (IA) administration o...
Autores principales: | Toupet, Karine, Jorgensen, Christian, Noël, Danièle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183038/ https://www.ncbi.nlm.nih.gov/pubmed/37179423 http://dx.doi.org/10.1038/s41598-023-34206-8 |
Ejemplares similares
-
Anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 beta®) in joint diseases
por: Baugé, Catherine, et al.
Publicado: (2015) -
Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis
por: Cosenza, Stella, et al.
Publicado: (2017) -
Thrombospondin-1 Partly Mediates the Cartilage Protective Effect of Adipose-Derived Mesenchymal Stem Cells in Osteoarthritis
por: Maumus, Marie, et al.
Publicado: (2017) -
Evaluation of expanded peripheral blood derived CD34+ cells for the treatment of moderate knee osteoarthritis
por: Vignon, Christine, et al.
Publicado: (2023) -
Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology
por: Maumus, Marie, et al.
Publicado: (2011)